[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355806-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355806-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","steroid-receptor-coactivators-in-immunity-from-function-to-emerging-translational-opportunities","Steroid Receptor Coactivators in Immunity - From Function to Emerging Translational Opportunities","","Steroid receptor coactivators (SRCs) are three paralogous proteins that act as essential transcriptional coactivators for nuclear receptors and a broad set of non-NR transcription factors. By enabling recruitment of chromatin modifiers and stabilizing transcriptional complexes, SRCs influence key physiological and pathological processes including development, metabolism, immunity, and cancer. Despite SRCs being attractive therapeutic targets, effective pharmacological targeting was challenging for decades until small-molecule modulators emerged, revealing unexpected immunomodulatory potential and enabling new translational strategies beyond cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/steroid-receptor-coactivators-in-immunity-from-function-to-emerging-translational-opportunities/355806/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/steroid-receptor-coactivators-in-immunity-from-function-to-emerging-translational-opportunities/355806.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are steroid receptor coactivators (SRCs) and what do they do?","Question",{"text":63,"@type":64},"SRCs are a family of three paralogous proteins that serve as transcriptional coactivators. They enable nuclear receptors’ transcriptional output and also regulate many non-NR transcription factors by supporting recruitment and stabilization of transcriptional complexes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why were SRCs considered difficult drug targets for many years?",{"text":68,"@type":64},"SRCs were viewed as “undruggable” due to their large size and the lack of a well-defined ligand-binding pocket.",{"name":70,"@type":61,"acceptedAnswer":71},"How did small-molecule modulators change the therapeutic view of SRCs?",{"text":72,"@type":64},"Discovery of small-molecule modulators made SRC activity pharmacologically targetable. Initial modulators supported cancer-focused exploration, and subsequent observations of immunomodulatory effects expanded therapeutic potential beyond cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355806,1790472572,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","REVIEWS  \nSteroid receptor coactivators in immunity-From function to emerging translational opportunities  \nReceived for publication, January 18, 2026, and in revised form, April 23, 2026 Published, Papers in Press, xxx [https://doi.org/10.1016/j.jbc.2026.1](https://doi.org/10.1016/j.jbc.2026.1)13087  \nYosef Gilad 1, * and David M. Lonard 1,2,*  \nFrom the 1Department ofMolecular and Cellular Biology and 2Nuclear Receptor, Transcription and Chromatin Biology Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA  \nReviewed by members of the JBC Editorial Board. Edited by Paul Shapiro  \nSteroid Receptor Coactivators (SRCs) comprise a family of three paralogous proteins. As transcriptional coactivators SRCs are essential for enabling the full transcriptional output of nuclear receptors (NRs). They regulate the transcriptional activity of nearly all NRs as well as a wide range of non–NR transcription factors. The central role of SRCs in gene regulation is reflected in their broad impact on major physiological and pathological processes, such as development, reproduction, metabolism, immunity and cancer. Although the major impact ofSRCs on human health and disease established them as attractive therapeutic targets, their effective pharmacological targeting remained a challenge for nearly 2 decades after their discovery. The discovery of small-molecule modulators enabled the exploration of targeting SRCs in cancer but soon presented opportunities for broader therapeutic applications. The immunomodulatory effects observed upon SRC inhibition or stimulation were unexpected yet exciting, revealing new therapeutic potential that extends beyond cancer as a sole indication. In this review, we first provide an overview of the central roles of SRCs in normal physiology and cancer and outline the process that enabled the development of small molecules capable of modulating SRC activity. Finally, we present a comprehensive account on the functions of SRCs in immunity and discuss how their pharmacological targeting and genetic manipulation can reshape immune responses, enabling the development of new therapeutic strategies in cancer and beyond.  \nNuclear receptors (NRs) comprise a family of 48 identified transcription factors (TFs) in humans (1), many of which are dependent on ligand binding for their activity (2). NRs bind to specific DNA sequences and interact with the general transcriptional machinery to regulate the transcription of specific target genes. Whether ligand-dependent or orphan, a properly regulated activity of NRs relies on a distinct family of proteins known as nuclear coregulators. Although coregulators are best known for their role as activators of NR transcriptional programs, they can regulate NR activity in both directionseither enhancing or suppressing it. In fact, the concept of  \n* For correspondence: Yosef Gilad, [yosi@bcm.edu](yosi@bcm.edu); David M. Lonard, [dlonard@bcm.edu](dlonard@bcm.edu).  \ncoregulation was first experimentally demonstrated by showing that the SSN6 protein functions as a corepressor, suppressing the hormone-dependent transcriptional activity of estrogen receptor (ER) and progesterone receptor (PR) (3). This was followed shortly by the discovery that Switch proteins are required for activation of another NR, glucocorticoid receptor (GR) in yeast (4). Experimentally establishing the concept of coactivation as a key component of gene expression ultimately led to the identification of the most dominant coregulator family – the SRC family. SRC-1 was the first family member to be identified (5), followed by the identification of SRC-2 (6) and SRC-3 (7–10). SRCs are central components of gene regulation that facilitate the recruitment of key chromatin modifiers such as CREB-binding protein (CBP), p300 (EP300), and coactivator-associated arginine methyltransferase 1 (CARM1) and stabilize multi-protein transcriptional complexes (11). These molecular interactions mediated by","cbCaiqpK5mF4kgIt","https://ap.wps.com/l/cbCaiqpK5mF4kgIt","pdf",9384111,"English","# Steroid receptor coactivators: core roles\n## SRCs as transcriptional coactivators and gene-regulation hubs\n## Nuclear coregulators and the concept of coactivation","[{\"question\":\"What are steroid receptor coactivators (SRCs) and what do they do?\",\"answer\":\"SRCs are a family of three paralogous proteins that serve as transcriptional coactivators. They enable nuclear receptors’ transcriptional output and also regulate many non-NR transcription factors by supporting recruitment and stabilization of transcriptional complexes.\"},{\"question\":\"Why were SRCs considered difficult drug targets for many years?\",\"answer\":\"SRCs were viewed as “undruggable” due to their large size and the lack of a well-defined ligand-binding pocket.\"},{\"question\":\"How did small-molecule modulators change the therapeutic view of SRCs?\",\"answer\":\"Discovery of small-molecule modulators made SRC activity pharmacologically targetable. Initial modulators supported cancer-focused exploration, and subsequent observations of immunomodulatory effects expanded therapeutic potential beyond cancer.\"}]","Steroid Receptor Coactivators in Immunity - From Function to Emerging Translational Opportunities | PDF",1790121088,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4dd316df9ab379252cbdd4c47b85b4a.webp",983,1296,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f04d80584481780bcdb499d1ef3b3943.webp",982,1294,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cb13cbf254afd20040d3d1e319f3114.webp",981,1293,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed609e5d64808a43d6d9162e9b3a8247.webp",980,1292]